He Miao, Lv Yan-Cheng, Wei Yu-Hong, Liu Lan-Qin, Guo Ling, Li Cheng
Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, Sichuan Province, China.
Department of Clinic Medicine, Southwest Medical University, Luzhou 646099, Sichuan Province, China.
World J Clin Cases. 2024 Jun 26;12(18):3582-3588. doi: 10.12998/wjcc.v12.i18.3582.
The aim of this study was to investigate the complex heterozygous mutations of and in the same individual and improve our understanding of hereditary spherocytosis (HS) in children. We also hope to promote the application of gene detection technology in children with HS, with the goals of identifying more related gene mutations, supporting the acquisition of improved molecular genetic information to further reveal the pathogenesis of HS in children, and providing important guidance for the diagnosis, treatment, and prevention of HS in children.
A 1-year and 5-month-old patient presented jaundice during the neonatal period, mild anemia 8 months later, splenic enlargement at 1 year and 5 months, and brittle red blood cell permeability. Genetic testing was performed on the patient, their parents, and sister. Swiss Model software was used to predict the protein structure of complex heterozygous mutations in and . Genetic testing revealed that the patient harbored a new mutation in the gene from the father and a mutation in the gene from the mother. Combined with the clinical symptoms of the children, it is suggested that the newly discovered complex heterozygous mutations of and may be the cause, providing important guidance for revealing the pathogenesis, diagnosis, treatment, and promotion of gene detection technology in children with HS.
This case involves an unreported complex heterozygous mutation of and , which provides a reference for exploring HS.
本研究旨在调查同一患者中[基因名称1]和[基因名称2]的复合杂合突变,增进我们对儿童遗传性球形红细胞增多症(HS)的理解。我们还希望推动基因检测技术在HS患儿中的应用,目标是鉴定更多相关基因突变,支持获取更完善的分子遗传学信息以进一步揭示儿童HS的发病机制,并为儿童HS的诊断、治疗和预防提供重要指导。
一名1岁5个月大的患者在新生儿期出现黄疸,8个月后出现轻度贫血,1岁5个月时脾脏肿大,红细胞脆性增加。对该患者及其父母和姐姐进行了基因检测。使用瑞士模型软件预测[基因名称1]和[基因名称2]复合杂合突变的蛋白质结构。基因检测显示,患者携带来自父亲的[基因名称1]新突变和来自母亲的[基因名称2]突变。结合患儿的临床症状,提示新发现的[基因名称1]和[基因名称2]复合杂合突变可能是病因,为揭示HS患儿的发病机制、诊断、治疗以及推动基因检测技术应用提供了重要指导。
本病例涉及未报道的[基因名称1]和[基因名称2]复合杂合突变,为探索HS提供了参考。